Navigation Links
Journal 'STEM CELLS' Presents 3rd Annual Young Investigator Award at International Stem Cell Symposium
Date:6/19/2008

Dr. Motoda named for fundamental cancer stem cell discovery

DURHAM, N.C. and SEOUL, Korea, June 19 /PRNewswire/ -- The journal STEM CELLS(R) announces that Lena Motoda, M.D., Ph.D. won the 3rd Annual STEM CELLS(R) Young Investigator Award. Co-sponsored by The International Stem Cell Symposium, the $10,000 prize is annually given to a young scientist who is the principal author of a research paper published in STEM CELLS judged to be most important by a worldwide jury. A medical graduate of The University of Tokyo, Dr. Motoda received her Ph.D. degree for her Young Investigator Award winning research conducted at the Institute of Molecular and Cell Biology, National University of Singapore, with the mentorship of Associate Professor Motomi Osato and Professor Yoshiaki Ito. Dr. Motoda is currently in the Department of Pediatrics, Toranomon Hospital, Tokyo.

STEM CELLS published Dr. Motoda's landmark paper that describes the importance of "RUNX1" as a molecular guardian of stem cells that produce blood cells. RUNX1, a transcription factor protein, protects these vital cells from cancer-inducing molecular insults by maintaining fail-safe cellular mechanisms. This may offer new therapeutic options for blood cell malignancies like leukemia and lymphoma. The article is freely available online: http://stemcells.alphamedpress.org/cgi/content/full/25/12/2976 .

Professor Miodrag Stojkovic, co-editor of STEM CELLS, remarked that, "Dr. Motoda's discovery demonstrates, once again, why it is essential to understand basic molecular mechanisms since these revelations may both help prevent disease and enable the development of novel and hopefully more effective therapeutic options." To which Professor Donald Phinney, STEM CELLS' other co-editor, remarked, "The manuscript by Motoda and her colleagues is an excellent example of how molecular mechanisms that regulate stem cell self-renewal, cell proliferation, and cell death are inextricably linked and how the perturbation of these pathways can cooperate to promote malignancies."

The 3rd annual award, presented on June 20th during the 6th Annual International Stem Cell Symposium, in Seoul, Korea, is considered one of the most important in this fast paced research arena. "The journal STEM CELLS is the oldest and most respected journal devoted to stem cell research and regenerative medicine. The International Stem Cell Symposium, now in its sixth year, is pleased to partner with this world-class journal," said Professor Il-Hoan Oh, Director of The Catholic University of Korea's Cell & Gene Therapy Institute and chair of the Symposium's organizing committee.

The International Stem Cell Symposium (http://www.cic.re.kr/symposium) has been organized annually by faculty of The Catholic University of Korea at which the most promising basic and clinical research dealing with stem cells and their therapeutic applications is critically discussed by cutting-edge researchers.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080619/CLTH010LOGO )

STEM CELLS(R) (http://www.StemCells.com), the international journal of cell differentiation and proliferation, publishes original articles and concise reviews describing basic laboratory investigations of stem cells and the translation to patient care. The Journal covers all aspects of stem cells and regenerative medicine. In its 26th year of publication, STEM CELLS is the first journal devoted to this fast-paced field of research. Its Impact Factor of 7.924 places it in the top 3% of all high-impact international journals.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080422/CLTU133LOGO-a )


'/>"/>
SOURCE The AlphaMed Company, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Dermatology Nurses Association Teams with International Publisher to Launch its Own Journal
2. Long-term safety data on Lialda published in leading GI journal
3. Long-Term Safety Data on Lialda(TM) (mesalamine) for Patients With Ulcerative Colitis Published in Leading GI Journal
4. American Heart Associations 3rd new journal -- Circulation: Cardiovascular Imaging
5. Harvard Study in Joint Commission Journal: Mortality Rates Lower in Leapfrog Hospitals
6. American Heart Associations Third New Journal - Circulation: Cardiovascular Imaging - Set for July Launch
7. American Heart Association Extends Sympathy to Family of Journalist Tim Russert
8. Essential dental treatment safe for pregnant women, says ADA journal study
9. MultiVu Video Feed: Study in the New England Journal of Medicine Shows High Blood Pressure Drug Tekturna(R) Reduces Key Marker of Kidney Disease
10. Journal of Ultrasound In Medicine features bioeffects consensus report
11. SAGE acquires 2 new medical journals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... ... April 24, 2017 , ... Michael Vick announced his retirement earlier this ... The former overall number one pick in the 2001 NFL Draft, to the Atlanta ... record for the most career rushing yards by a quarterback (6,109) and the most ...
(Date:4/24/2017)... ... , ... As part of the nationwide Days of Remembrance effort led by ... and Nazi persecution, Center for Medicine after the Holocaust (CMATH) announced that ... to Germany and Poland next week. , The Fourth Biennial CMATH Champions Trip to ...
(Date:4/24/2017)... ... ... Bright Pink , a national non-profit organization focusing on the prevention and early detection ... Pink is proud to announce Katie Thiede as their new Chief Executive Officer. In January, ... Chairman of the Board and launched a national search to find a visionary new leader ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... Veteran Theresa ... happened next changed her life forever. , In “Healing Tears,” James depicts every parent’s ... advice of my attorney, I began journaling conversations and situations throughout my divorce,” James ...
(Date:4/24/2017)... McLean, Virginia (PRWEB) , ... April 24, 2017 ... ... have announced that they are seeking public support to bring their novel lifesaving ... in appearance, wearable device packed with medical-grade sensors, specially designed to read a ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)...  AbbVie (NYSE: ABBV), a global biopharmaceutical company, ... hepatitis C virus (HCV) infected patients with genotype ... cirrhosis (Child-Pugh A) achieved sustained virologic response at ... investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high ... weeks of G/P treatment without ribavirin. Patients with ...
(Date:4/20/2017)... Sweden , April 20, 2017 ... NEVPF) ("NeuroVive") today announced positive preclinical results ... preclinical compound for non-alcoholic steatohepatitis (NASH), in ... NV556 has previously shown ... NASH model. Today, NeuroVive,s scientists present novel ...
(Date:4/19/2017)... , April 19, 2017 Cardiology devices segment is ... period The Cardiology Devices segment is likely to ... 15 Mn in 2018 over 2017. By the end of ... valuation close to US$ 700 Mn, expanding at a CAGR ... dominated the Asia Pacific reprocessed medical ...
Breaking Medicine Technology: